Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evidence-based medicine. Interpreting studies and setting policy.

S H Woolf1, J N George

  • 1Department of Family Practice, Medical College of Virginia-Virginia Commonwealth University, Fairfax, USA.

Hematology/Oncology Clinics of North America
|August 19, 2000
PubMed
Summary

Evidence-based medicine (EBM) has limitations, as randomized controlled trials (RCTs) are costly and not always feasible. Guidelines, while intended to improve care, can be flawed and difficult to implement effectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hereditary thrombotic thrombocytopenic purpura and the hereditary TTP registry.

Hamostaseologie·2013
Same author

The Oklahoma Thrombotic Thrombocytopenic Purpura-haemolytic Uraemic Syndrome Registry. A model for clinical research, education and patient care.

Hamostaseologie·2013
Same author

Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP).

Journal of thrombosis and haemostasis : JTH·2010
Same author

Developing clinical guidelines.

The Western journal of medicine·2008
Same author

Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: defining a disorder.

Bone marrow transplantation·2008
Same author

Management of patients with refractory immune thrombocytopenic purpura.

Journal of thrombosis and haemostasis : JTH·2006

Area of Science:

  • Medical Research Methodology
  • Health Policy
  • Clinical Practice

Background:

  • The widespread adoption of Evidence-Based Medicine (EBM) has highlighted its inherent limitations and challenges.
  • The high cost, duration, and complexity of Randomized Controlled Trials (RCTs) restrict their applicability to all medical questions.
  • Concerns exist regarding the suitability of current study designs and measurement tools for addressing patient-centered quality issues.

Purpose of the Study:

  • To critically evaluate the effectiveness and limitations of Evidence-Based Medicine (EBM) and clinical practice guidelines.
  • To explore the reasons behind the limited impact of guidelines on clinical practice and patient outcomes.
  • To identify barriers to behavior change and propose strategies for effective implementation of evidence into practice.

Related Experiment Videos

Main Methods:

  • Analysis of the shortcomings of EBM and RCTs.
  • Review of the development and implementation challenges of clinical practice guidelines.
  • Examination of factors influencing clinician behavior change.

Main Results:

  • Lack of evidence for effectiveness does not equate to ineffectiveness, yet is often used to deny coverage.
  • Many practice guidelines are poorly developed, and flawed guidelines can lead to patient harm.
  • Disseminating guidelines alone does not motivate clinicians; implementation strategies beyond simple recommendations are necessary.

Conclusions:

  • The limitations of EBM and guidelines necessitate a move beyond simple dissemination to thoughtful implementation strategies.
  • Addressing barriers to behavior change is crucial for improving clinical practice and patient outcomes.
  • Continued research and innovative approaches are needed to identify effective medical interventions and practices.